NanoViricides
NNVC
25 hedge funds and large institutions have $2.09M invested in NanoViricides in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
1,750% more call options, than puts
Call options by funds: $37K | Put options by funds: $2K
0.49% less ownership
Funds ownership: 10.14% → 9.65% (-0.49%)
7% less funds holding
Funds holding: 27 → 25 (-2)
14% less capital invested
Capital invested by funds: $2.45M → $2.09M (-$354K)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.94K |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.58K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$1.84K |
| 4 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
+$539 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$92 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$52.5K |
| 2 |
Renaissance Technologies
New York
|
-$30.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$11.4K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$5.43K |
| 5 |
AW
Alaethes Wealth
Glenbrook,
Nevada
|
-$4K |
NNVC Hedge Fund Activity: Q2 2022 in Review
25 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2022, worth a combined $2.09M — down 14% from $2.45M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NNVC and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Geode Capital Management, adding an estimated $2.94K. The largest seller was BlackRock, cutting an estimated $52.5K.
- 25 institutional investors held NanoViricides (NNVC) as of Q2 2022, down from 27 in Q1 2022.
- Funds reported $2.09M of NanoViricides stock for Q2 2022, down 14% quarter-over-quarter.
- 2 funds opened new NanoViricides positions in Q2 2022 and 4 closed out, a net change of -2 holders.
- The largest NanoViricides buyer in Q2 2022 was Geode Capital Management, an estimated $2.94K added.
- The largest NanoViricides seller in Q2 2022 was BlackRock, an estimated $52.5K sold.
Based on aggregated 13F filings for Q2 2022.